DekaBank Deutsche Girozentrale’s Collegium Pharmaceutical COLL Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,008	Closed	-$349K	–	1387
2022 Q2	$349K	Sell	20,008 -15,320	-43%	-$258K	﹤0.01%	1087
2022 Q1	$708K	Buy	+35,328	New	+$667K	﹤0.01%	984
2021 Q4	–	Sell	-10,400	Closed	-$204K	–	1434
2021 Q3	$204K	Hold	10,400	–	–	﹤0.01%	1205
2021 Q2	$252K	Hold	10,400	–	–	﹤0.01%	1176
2021 Q1	$247K	Hold	10,400	–	–	﹤0.01%	1148
2020 Q4	$205K	Hold	10,400	–	–	﹤0.01%	1179
2020 Q3	$204K	Buy	+10,400	New	+$188K	﹤0.01%	1049
2019 Q3	–	Sell	-21,600	Closed	-$286K	–	1018
2019 Q2	$286K	Buy	21,600 +8,400	+64%	+$112K	﹤0.01%	977
2019 Q1	$221K	Buy	13,200 +2,400	+22%	+$38.4K	﹤0.01%	1026
2018 Q4	$176K	Sell	10,800 -2,400	-18%	-$41.1K	﹤0.01%	988
2018 Q3	$221K	Sell	13,200 -300	-2%	-$5.32K	﹤0.01%	1048
2018 Q2	$329K	Hold	13,500	–	–	﹤0.01%	982
2018 Q1	$338K	Buy	+13,500	New	+$322K	﹤0.01%	932
2016 Q2	–	Sell	-10,100	Closed	-$172K	–	1003
2016 Q1	$172K	Buy	+10,100	New	+$184K	﹤0.01%	871

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DekaBank Deutsche Girozentrale's COLL Position: Q3 2022 in Review

DekaBank Deutsche Girozentrale sold out of Collegium Pharmaceutical (COLL) in Q3 2022, closing a stake of 20,008 shares — an estimated $349K sold.

DekaBank Deutsche Girozentrale first reported a position in COLL in Q1 2016 and held it in 14 quarters. The position peaked at $708K in Q1 2022. 168 funds tracked by Wall St. Rank hold COLL as of Q3 2022.

DekaBank Deutsche Girozentrale reported no remaining Collegium Pharmaceutical position as of Q3 2022 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 20,008 Collegium Pharmaceutical shares in Q3 2022, an estimated $349K.
DekaBank Deutsche Girozentrale first reported a position in Collegium Pharmaceutical in Q1 2016 and held it in 14 quarters.
DekaBank Deutsche Girozentrale's Collegium Pharmaceutical position peaked at $708K in Q1 2022.
168 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.